CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Malliga R. Iyer - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Malliga R. Iyer

ORCID: 0000-0002-0116-4619↗

Public evidence

6 connected articles

Anandamide is an Early Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis2024 · medRxiv Brain CB2 receptor: a new target in medication development for treating opioid use disorder in rodents.2026 · Europe PMC A Novel Approach for the Synthesis of Peripherally Acting Dual Target Inhibitor of Cannabinoid-1 (CB1 Receptor) and Inducible Nitric Oxide Synthase (iNOS) (<i>S</i>-MRI-1867/Zevaquenabant).2026 · Europe PMC CB<sub>1</sub> receptors on a subset of vagal afferent neurons modulate voluntary ethanol intake in mice.2026 · Europe PMC Pharmacological Evaluation of Cannabinoid Receptor Modulators Using GRAB<sub>eCB2.0</sub> Sensor.2024 · PubMed Central Open Access Rational Design, Synthesis, and Evaluation of Fluorescent CB<sub>2</sub> Receptor Ligands for Live-Cell Imaging: A Comprehensive Review.2023 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.